Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Divi’s Laboratories Limited ( (IN:DIVISLAB) ) just unveiled an announcement.
Divi’s Laboratories Limited announced the closure of its trading window from July 1, 2025, until 48 hours after the release of its unaudited financial results for the quarter ending June 30, 2025. This move is in compliance with the company’s Code of Conduct to regulate trading by insiders and is a routine procedure aimed at ensuring transparency and preventing insider trading.
More about Divi’s Laboratories Limited
Divi’s Laboratories Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company is a significant player in the global pharmaceutical market, providing essential components for various medications.
Average Trading Volume: 19,594
Current Market Cap: 1767.5B INR
Learn more about DIVISLAB stock on TipRanks’ Stock Analysis page.